# Retrograde Cricopharyngeal Dysfunction: An Update of Pathophysiological Mechanisms and Future Directions

**Authors:** Marie Mailly, Jerome R. Lechien

PMC · DOI: 10.3390/toxins18010008 · Toxins · 2025-12-22

## TL;DR

This review summarizes the causes and mechanisms of retrograde cricopharyngeal dysfunction, highlighting gaps in understanding and the need for future research.

## Contribution

The paper provides an updated overview of R-CPD mechanisms and identifies areas for future investigation.

## Key findings

- Family history and childhood onset are common in R-CPD patients.
- Gastroesophageal and laryngopharyngeal reflux are prevalent in R-CPD.
- Botulinum toxin provides long-term symptom relief, suggesting neuroplastic adaptation.

## Abstract

This scoping review aimed to summarize the current literature on the etiological and pathophysiological mechanisms associated with the development of retrograde cricopharyngeus dysfunction (R-CPD) through a PRISMA literature search. According to the current literature, a family history of R-CPD was reported in 28.0% of patients across studies, with childhood onset in 55.5% of cases. Gastroesophageal reflux disease and laryngopharyngeal reflux disease prevalence in R-CPD patients ranged from 16.3 to 51.9%, with improvement of heartburn symptoms after treatment. High-resolution manometry revealed dysmotility disorders in 43.5–80.0% of patients, with absent peristalsis in 11–25%. Carbonated drink provocative testing provided diagnostic usefulness in patients with unclear diagnoses by demonstrating failure of cricopharyngeal sphincter relaxation for retrograde gas. Notably, 75.5–79.9% of patients maintained symptom relief beyond the expected pharmacologic duration of botulinum toxin (approximately 6 months), suggesting potential neuroplastic adaptation or learned compensatory mechanisms in overcoming retrograde cricopharyngeal sphincter dysfunction. The pathophysiology of R-CPD remains incompletely understood, with a lack of epidemiological and pediatric studies. The genetic and environmental factors may play a key role, but future studies are needed to clarify their roles in the development of R-CPD.

## Linked entities

- **Diseases:** gastroesophageal reflux disease (MONDO:0007186)

## Full-text entities

- **Diseases:** Gastroesophageal reflux disease (MESH:D005764), Cricopharyngeal Dysfunction (MESH:D006331), R-CPD (MESH:D012183), cricopharyngeal sphincter dysfunction (MESH:D046628), dysmotility disorders (MESH:D015154), absent peristalsis (MESH:D012021), laryngopharyngeal reflux disease (MESH:D057045), heartburn (MESH:D006356)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12846232/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12846232/full.md

## References

37 references — full list in the complete paper: https://tomesphere.com/paper/PMC12846232/full.md

---
Source: https://tomesphere.com/paper/PMC12846232